BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2014182)

  • 1. Factor IXBasel: a Swiss family with severe haemophilia B having a point mutation in EGF type B domain.
    Alkan M; Rodriguez Ponte M; Malik NJ; Hofmann S; Bösch-Al Jadooa N; Müller H; Bühler EM
    Nucleic Acids Res; 1991 Jan; 19(2):409. PubMed ID: 2014182
    [No Abstract]   [Full Text] [Related]  

  • 2. A less severe form of Haemophilia B Leyden.
    Crossley M; Winship PR; Austen DE; Rizza CR; Brownlee GG
    Nucleic Acids Res; 1990 Aug; 18(15):4633. PubMed ID: 2388855
    [No Abstract]   [Full Text] [Related]  

  • 3. A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B.
    Vidaud M; Chabret C; Gazengel C; Grunebaum L; Cazenave JP; Goossens M
    Blood; 1986 Oct; 68(4):961-3. PubMed ID: 2875754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B.
    Lozier JN; Monroe DM; Stanfield-Oakley S; Lin SW; Smith KJ; Roberts HR; High KA
    Blood; 1990 Mar; 75(5):1097-104. PubMed ID: 2306516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilia B Liverpool: a new British family with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter.
    Stowell KM; Figueiredo MS; Brownlee GG; Jones P; Bolton-Maggs PH
    Br J Haematol; 1993 Sep; 85(1):188-90. PubMed ID: 8251390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of factor IX mutations in Iranian haemophilia B patients by SSCP and sequencing.
    Karimipoor M; Zeinali S; Nafissi N; Tuddenham EG; Lak M; Safaee R
    Thromb Res; 2007; 120(1):135-9. PubMed ID: 17014892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation (Val-373 to Glu) in the catalytic domain of factor IX, resulting in moderately/severe hemophilia B in a southern French patient.
    Aguilar-Martinez P; Romey MC; Gris JC; Schved JF; Demaille J; Claustres M
    Hum Mutat; 1994; 3(2):156-8. PubMed ID: 8199596
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region.
    Royle G; Van de Water NS; Berry E; Ockelford PA; Browett PJ
    Br J Haematol; 1991 Feb; 77(2):191-4. PubMed ID: 2004020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B.
    Vielhaber E; Jacobson DP; Ketterling RP; Liu JZ; Sommer SS
    Hum Mol Genet; 1993 Aug; 2(8):1309-10. PubMed ID: 8401514
    [No Abstract]   [Full Text] [Related]  

  • 10. Splice junction mutations in factor IX gene resulting in severe hemophilia B.
    Chen SH; Zhang M; Thompson AR; Bray GL; Scott CR
    Nucleic Acids Res; 1991 Mar; 19(5):1172. PubMed ID: 2020563
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemophilia B caused by a missense mutation in the prepeptide sequence of factor IX.
    Green PM; Mitchell VE; McGraw A; Goldman E; Giannelli F
    Hum Mutat; 1993; 2(2):103-7. PubMed ID: 8318985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype analysis of identical factor IX mutants using PCR.
    Green PM; Montandon AJ; Ljung R; Nilsson IM; Giannelli F
    Thromb Haemost; 1992 Jan; 67(1):66-9. PubMed ID: 1615486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilia B: database of point mutations and short additions and deletions.
    Giannelli F; Green PM; High KA; Lozier JN; Lillicrap DP; Ludwig M; Olek K; Reitsma PH; Goossens M; Yoshioka A
    Nucleic Acids Res; 1990 Jul; 18(14):4053-9. PubMed ID: 2377450
    [No Abstract]   [Full Text] [Related]  

  • 14. Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B.
    Poort SR; Briët E; Bertina RM; Reitsma PH
    Thromb Haemost; 1990 Nov; 64(3):379-84. PubMed ID: 2096489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new hemophilia B mutation in the propeptide region of the FIX gene.
    Chan V; Chan VW; Cherk S; Chan TK
    Am J Hematol; 1995 Oct; 50(2):144-5. PubMed ID: 7572994
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor IX mutations: rapid, direct screening methods for 20 new families with hemophilia B.
    Thompson AR; Schoof JM; Weinmann AF; Chen SH
    Thromb Res; 1992 Jan; 65(2):289-95. PubMed ID: 1579901
    [No Abstract]   [Full Text] [Related]  

  • 17. Twenty-five novel mutations of the factor IX gene in haemophilia B.
    Wulff K; Schröder W; Wehnert M; Herrmann FH
    Hum Mutat; 1995; 6(4):346-8. PubMed ID: 8680410
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of haemophilia B patients with mutations in the two calcium binding domains of factor IX: importance of a beta-OH Asp 64----Asn change.
    Winship PR; Dragon AC
    Br J Haematol; 1991 Jan; 77(1):102-9. PubMed ID: 1998585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of factor IX defects in hemophilia B patients.
    Thompson AR; Chen SH
    Methods Enzymol; 1993; 222():143-69. PubMed ID: 8412791
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a factor IX point mutation using SSCP analysis and direct sequencing.
    Demers DB; Odelberg SJ; Fisher LM
    Nucleic Acids Res; 1990 Sep; 18(18):5575. PubMed ID: 2216751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.